gabapentin
Generic: gabapentin
Labeler: advagen pharma ltdDrug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
advagen pharma ltd
Dosage Form
TABLET
Routes
Active Ingredients
gabapentin 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72888-132
Product ID
72888-132_4b9217ba-8356-aab1-e063-6294a90a2dce
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077661
Listing Expiration
2027-12-31
Marketing Start
2022-09-22
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72888132
Hyphenated Format
72888-132
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA077661 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 1000 TABLET in 1 BOTTLE (72888-132-00)
- 100 TABLET in 1 BOTTLE (72888-132-01)
- 500 TABLET in 1 BOTTLE (72888-132-05)
- 30 TABLET in 1 BOTTLE (72888-132-30)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4b9217ba-8356-aab1-e063-6294a90a2dce", "openfda": {"nui": ["N0000008486"], "upc": ["0372888132013", "0372888132051", "0372888132303", "0372888131306", "0372888131016", "0372888131009", "0372888132006", "0372888131054"], "unii": ["6CW7F3G59X"], "rxcui": ["310433", "310434"], "spl_set_id": ["401b30fc-e143-4906-aae1-e5b5c190d4a8"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Advagen Pharma Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (72888-132-00)", "package_ndc": "72888-132-00", "marketing_start_date": "20220922"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (72888-132-01)", "package_ndc": "72888-132-01", "marketing_start_date": "20220922"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (72888-132-05)", "package_ndc": "72888-132-05", "marketing_start_date": "20220922"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (72888-132-30)", "package_ndc": "72888-132-30", "marketing_start_date": "20220922"}], "brand_name": "Gabapentin", "product_id": "72888-132_4b9217ba-8356-aab1-e063-6294a90a2dce", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72888-132", "generic_name": "gabapentin", "labeler_name": "Advagen Pharma Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "800 mg/1"}], "application_number": "ANDA077661", "marketing_category": "ANDA", "marketing_start_date": "20220922", "listing_expiration_date": "20271231"}